Search Results

If you make changes to this saved search, you'll find the original and new searches in your account.

Your search filters:

LICENSING AGREEMENTS

Showing 1-10 of about 1100 articles.

Arbutus Biopharma Corporation

Arbutus Announces Corporate Update and First Quarter 2018 Financial Results

May 03, 2018

Apricus Biosciences, Inc.

Apricus Biosciences Announces Outcome of Vitaros™ End-of-Review Meeting with FDA

April 16, 2018

Arbutus Biopharma Corporation

Arbutus and Roivant Launch Genevant Sciences with Industry-Leading Platform to Develop Broad Range of RNA Therapeutics for Genetic Diseases

April 11, 2018

VB_Logo_Black[1].jpg

Vera Bradley, Inc.

Vera Bradley Announces New Licensing Agreement for Sleepwear/Loungewear

March 14, 2018

Arbutus Biopharma Corporation

Arbutus Settles Litigation, Terminating Acuitas’ Rights to LNP Technology

February 22, 2018

Apricus Biosciences, Inc.

Apricus Biosciences Receives Complete Response Letter from FDA for Vitaros™

February 16, 2018

Arbutus Biopharma Corporation

Arbutus Enters Exclusivity Agreement with Roivant Sciences

February 14, 2018

Arbutus Biopharma Corporation

Arbutus’ LNP Licensee Alnylam Initiates Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Patisiran

November 16, 2017

Arbutus Biopharma Corporation

Arbutus’ LNP Licensee Alnylam Receives Accelerated Assessment of Patisiran from European Medicines Agency (EMA)

November 13, 2017

Arbutus Biopharma Corporation

Arbutus Announces Corporate Update and Third Quarter 2017 Financial Results

November 02, 2017

Showing 1-10 of about 1100 articles.

© 2018 GlobeNewswire, Inc. All Rights Reserved.